Fosun Pharma (600196.SH): FXS887 tablets approved for clinical trials in late-stage malignant solid tumors.

Zhtng cijng APP xn, fxng yyo (600196.SH) fb gnggo, jnr, gngs kngg zgngs shnghi fxng yyo chny fzhn yuxin gngs (yxi jinchng fxng yyo chny) shudo guji yopn jind gunl j guny tngy FXS887 pin (xingm diho j yxi jinchng FXS0887) yngy wnq mngs sht li kizhn lnghu shyn de pzhn. Fxng yyo chny n y tiojin jbi hu y zhnggu jngni kizhn FXS0887 de I q lnghu shyn.